Dyadic International Stock Today
| DYAI Stock | USD 1.40 0.03 2.10% |
PerformanceVery Weak
| Odds Of DistressAbout Average
|
Dyadic International is trading at 1.40 as of the 21st of March 2025. This is a 2.1 percent decrease since the beginning of the trading day. The stock's open price was 1.43. Dyadic International has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 21st of December 2024 and ending today, the 21st of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of November 2004 | Category Healthcare | Classification Health Care |
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. Dyadic International operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 29.48 M outstanding shares of which 120.64 K shares are currently shorted by private and institutional investors with about 6.73 trading days to cover. More on Dyadic International
Moving together with Dyadic Stock
Moving against Dyadic Stock
Dyadic Stock Highlights
| Chairman | Mark Emalfarb | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Biotech, Pharmaceutical Products, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt LevelsDyadic International can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Dyadic International's financial leverage. It provides some insight into what part of Dyadic International's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dyadic International (DYAI) is traded on NASDAQ Exchange in USA. It is located in 1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094 and employs 7 people. Dyadic International is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 33.6 M. Dyadic International conducts business under Biotechnology sector and is part of Health Care industry. The entity has 29.48 M outstanding shares of which 120.64 K shares are currently shorted by private and institutional investors with about 6.73 trading days to cover.
Dyadic International currently holds about 15.64 M in cash with (6.73 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.55.
Check Dyadic International Probability Of Bankruptcy
Ownership AllocationDyadic International holds a total of 29.48 Million outstanding shares. Dyadic International retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Dyadic Ownership Details
Dyadic Stock Institutional Holders
| Instituion | Recorded On | Shares | |
| Barclays Plc | 2024-12-31 | 72.0 |
Dyadic International Historical Income Statement
Dyadic Stock Against Markets
Dyadic International Corporate Management
| Ronen Tchelet | VP of Bus. Devel. for Europe | Profile | |
| Joseph Hazelton | Chief Officer | Profile | |
| Doug BA | Executive Development | Profile | |
| Ana Rodriguez | Secretary Board | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Dyadic International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more detail on how to invest in Dyadic Stock please use our How to Invest in Dyadic International guide.You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyadic International. If investors know Dyadic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyadic International listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.27) | Revenue Per Share | Quarterly Revenue Growth (0.54) | Return On Assets | Return On Equity |
The market value of Dyadic International is measured differently than its book value, which is the value of Dyadic that is recorded on the company's balance sheet. Investors also form their own opinion of Dyadic International's value that differs from its market value or its book value, called intrinsic value, which is Dyadic International's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyadic International's market value can be influenced by many factors that don't directly affect Dyadic International's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyadic International's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyadic International is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyadic International's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.